About SequenceBase and USGENE®USGENE® provides searchable access to all available peptide and nucleotide sequences from the published applications and issued patents of the United States Patent and Trademark Office (USPTO). Sequence data are available in USGENE within only 3 days of publication by the USPTO.
USGENE is the unparalleled resource in which to perform nucleic acid and protein U.S. patent sequence searching. The database has an archive which dates back to 1981, and unrivalled sequence data timeliness of within 3 days of USPTO publication.
USGENE is the only dedicated, unified source for all available USPTO sequence data.
The USGENE database provides: - Comprehensive sequence data and related annotations, including organism name, sequence length, feature tables, molecule type and patent location (claimed, etc).
- Extensive bibliographic search options, including patent assignee (owner) names, inventor names, publication, application and foreign priority numbers and dates.
- Flexible patent text search options, including original title, abstract and claims.
USGENE is available via: A summary of USGENE coverage and an annotated sample record are available.
Please fill out the Contact form if you have further questions about USGENE, content or coverage. Someone from our organization will contact you shortly.
About the SequenceBase Corporation
The SequenceBase Corporation is a leader in providing patent sequence information to the biotech, legal, pharmaceutical, scientific, technical and academic bioinformatics communities. USGENE is our unparalleled resource for freedom-to-operate, validity, infringement and prior-art intellectual property sequence searches, competitive analysis of organizations with gene patent publications, and current awareness alerts (SDIs) from the very latest USPTO polypeptide, DNA and RNA sequence data. In addition to producing USGENE on STN®, we provide customized subscription download services of USGENE data to a wide variety of clients, in multiple standard formats to suit their in-house molecular biology patent information needs. Our President and CEO
Dr. Martin Goffman, President, Chief Executive Officer and founder of SequenceBase Corporation holds a Ph.D. in Chemistry from Temple University and has owned and operated small high technology businesses for the past 20 years. In addition to his involvement in the SequenceBase Corporation, Dr. Goffman is also a co-founder of StockPricePredictor.com, LLC. Dr. Goffman maintains his long time passion of information research, particularly in the patent information and related technology fields, and he is the principal of Martin Goffman Associates.
|
